Covaxin trial
Bharat Biotech completes phase 2/3 trials of Covaxin for children under 18 years
On the production levels of Covaxin, Ella said 100 million doses per month can be possible
Bharat Biotech's Covaxin trials suspended in Brazil after graft allegations
Bharat Biotech had on Friday announced cancellation of the MoU it signed for its COVID-19 vaccine Covaxin for the Brazilian market
AIIMS to start recruitment for Covaxin clinical trial in 6-12 age group from Tuesday
This will be followed by the clinical trial of children in the age-group of 2-6 years
Bhopal gas tragedy survivors demand halt to ‘unethical’ vaccine trial
The NGOs allege that the consent procedure and other protocol of testing are being thrown to winds
Covaxin to use ViroVax's adjuvant Alhydroxiquim-II to boost immune response
Bharat Biotech is currently conducting Phase II human trials of Covaxin after receiving approval from the Drug Controller General of India
Covaxin test on animals show sign of hope
The animal trials were conducted on 20 monkeys in India and three different vaccine candidates were tried on them